KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $1.6 billion.

  • Boston Scientific's Cost of Revenue rose 968.62% to $1.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.2 billion, marking a year-over-year increase of 1833.75%. This contributed to the annual value of $6.2 billion for FY2025, which is 1833.75% up from last year.
  • According to the latest figures from Q4 2025, Boston Scientific's Cost of Revenue is $1.6 billion, which was up 968.62% from $1.5 billion recorded in Q3 2025.
  • Over the past 5 years, Boston Scientific's Cost of Revenue peaked at $1.6 billion during Q2 2025, and registered a low of $894.0 million during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $1.1 billion (2023), whereas its average is $1.2 billion.
  • As far as peak fluctuations go, Boston Scientific's Cost of Revenue crashed by 280.0% in 2021, and later surged by 2889.76% in 2025.
  • Quarter analysis of 5 years shows Boston Scientific's Cost of Revenue stood at $972.0 million in 2021, then grew by 4.01% to $1.0 billion in 2022, then rose by 13.45% to $1.1 billion in 2023, then rose by 27.81% to $1.5 billion in 2024, then rose by 9.69% to $1.6 billion in 2025.
  • Its Cost of Revenue was $1.6 billion in Q4 2025, compared to $1.5 billion in Q3 2025 and $1.6 billion in Q2 2025.